Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

COSMIC-3D provides structural perspectives on cancer genetics for drug discovery

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Individual views of mutation, mutation frequency and protein sequence in COSMIC-3D.


  1. Forbes, S. A. et al. Nucleic Acids Res. 45 (D1), D777–D783 (2017).

  2. Berman, H. M. et al. Curr. Opin. Struct. Biol. 40, 17–22 (2016).

    Article  CAS  Google Scholar 

  3. Velankar, S. et al. Nucleic Acids Res. 41, D483–D489 (2013).

    Article  CAS  Google Scholar 

  4. Futreal, P. A. et al. Nat. Rev. Cancer 4, 177–183 (2004).

    Article  CAS  Google Scholar 

  5. Rose, A. S. & Hildebrand, P. W. Nucleic Acids Res. 43 (W1), W576–W579 (2015).

  6. UniProt Consortium. Nucleic Acids Res. 45, D158–D169 (2017).

    Article  Google Scholar 

  7. Le Guilloux, V., Schmidtke, P. & Tuffery, P. BMC Bioinformatics 10, 168 (2009).

    Article  Google Scholar 

  8. Gilmer, T. M. et al. Cancer Res. 68, 571–579 (2008).

    Article  CAS  Google Scholar 

  9. Gazdar, A. F. Oncogene 28 (Suppl. 1), S24–S31 (2009).

Download references


We thank colleagues at the Wellcome Sanger Institute and Astex Pharmaceuticals for helpful comments. This work was funded by a postdoctoral fellowship awarded to H.C.J. under the Sustaining Innovation Postdoctoral Training Program at Astex Pharmaceuticals (H.C.J., H.K.S., M.L.V., S.A.F.). This work was supported by a Wellcome Trust grant (206194) (H.C.J., S.A.F.).

Author information

Authors and Affiliations



H.C.J. contributed experimental design, performed the experiments, analyzed the data and wrote the manuscript. H.K.S., M.L.V. and S.A.F. contributed joint supervision of research, conception and design of the experiments, and writing of the manuscript.

Corresponding author

Correspondence to Harry C. Jubb.

Ethics declarations

Competing interests

COSMIC-3D uses data and systems infrastructure from the COSMIC database group, which is partly funded from Wellcome Trust charitable funds together with sales of licenses to for-profit enterprises. H.K.S. and M.L.V. are employed by Astex Pharmaceuticals.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jubb, H.C., Saini, H.K., Verdonk, M.L. et al. COSMIC-3D provides structural perspectives on cancer genetics for drug discovery. Nat Genet 50, 1200–1202 (2018).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer